- Research works
- 77 ▼ 61% vs 2013–17
- Citations
- 2.8k 36.6 per fractional work
- Top-10% rate
- 2.2% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: Minophagen Pharmaceutical (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Minophagen Pharmaceutical (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Antioxidant, Pharmacology, Cancer, Inflammation, Antiviral, Anti-inflammatory, Bioactive Compounds and Hepatoprotective.
- Scaffold
- Neuroprotective Effects
- Pharmacological Effects
- Cancer Prevention
- Microwave-Assisted Synthesis
- Medicinal Chemistry
- Saponins
- Heterocycles
- Anticancer Agents
- Drug Discovery
- Apoptosis
- Wound Healing
- Biological Evaluation
- Antioxidant Activity
- Anticancer
- Glycyrrhizin
- Hepatoprotective
- Anti-inflammatory
- Inflammation
- Pharmacology
- Antioxidant
- Cancer
- Antiviral
- Bioactive Compounds
- Herbal Medicine
- Licorice
- Synthesis
- Toxicity
- Antimicrobial
- Aloe Vera
- Emodin
- Metabolism
- Biological Activities
- Pharmacological Properties
- Triterpenoids
- Angiogenesis
- Pharmacokinetics
- Cytotoxicity
- Molecular Docking
- Heterocyclic Compounds
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antioxidant20▲ 38×8 topics
- Pharmacology17▲ 67×10 topics
- Cancer16▲ 15×18 topics
- Inflammation16▲ 8.8×27 topics
- Antiviral13▲ 181×2 topics
- Anti-inflammatory12▲ 52×8 topics
- Bioactive Compounds10▲ 71×4 topics
- Hepatoprotective10▲ 166×2 topics
- Herbal Medicine10▲ 57×3 topics
- Glycyrrhizin10▲ 307×1 topic
- Licorice10▲ 307×1 topic
- Anticancer9▲ 61×8 topics
- Synthesis7▲ 16×10 topics
- Antioxidant Activity5▲ 13×13 topics
- Toxicity5▲ 15×3 topics
- Biological Evaluation5▲ 52×4 topics
- Antimicrobial4▲ 22×6 topics
- Wound Healing4▲ 25×3 topics
- Aloe Vera4▲ 652×1 topic
- Apoptosis4▲ 14×5 topics
- Emodin4▲ 652×1 topic
- Drug Discovery4▲ 13×4 topics
- Metabolism4▲ 8.0×7 topics
- Anticancer Agents4▲ 18×5 topics
- Biological Activities4▲ 25×2 topics
- Heterocycles3▲ 24×4 topics
- Pharmacological Properties3▲ 62×1 topic
- Saponins3▲ 89×1 topic
- Triterpenoids3▲ 68×2 topics
- Medicinal Chemistry3▲ 11×4 topics
- Angiogenesis3▲ 9.4×9 topics
- Microwave-Assisted Synthesis3▲ 46×2 topics
- Pharmacokinetics3▲ 13×3 topics
- Cancer Prevention3▲ 14×5 topics
- Cytotoxicity2▲ 23×3 topics
- Pharmacological Effects2▲ 40×3 topics
- Molecular Docking2▲ 22×2 topics
- Neuroprotective Effects2▲ 25×4 topics
- Heterocyclic Compounds2▲ 19×3 topics
- Scaffold2▲ 31×1 topic
Which research topics does Minophagen Pharmaceutical (Japan) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Medical Malpractice and Liability Issues, Bone fractures and treatments and Chromatin Remodeling and Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
- 2 Medical Malpractice and Liability Issues Pharmacy 0 works
- 3 Bone fractures and treatments Epidemiology 0 works
- 4 Chromatin Remodeling and Cancer Molecular Biology 0 works
- 5 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 6 Peptidase Inhibition and Analysis Oncology 0 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Orthopedic Surgery and Rehabilitation Surgery 0 works
- 9 Vascular Tumors and Angiosarcomas Oncology 0 works
- 10 Urologic and reproductive health conditions Rheumatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Minophagen Pharmaceutical (Japan)'s research output changed?
Output in 2018–2022 was 61% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.